Advanced in Metastatic Brain Tumor

Mark A. Crowther

St. Joseph's Hospital, 
Hamilton, ON, CA 
Advanced in Metastatic Brain Tumor
St. Joseph's Hospital, 
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Mark Crowther practices in Hamilton, Canada. Mr. Crowther is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Antiphospholipid Syndrome, Hip Replacement, and Coronary Artery Bypass Graft (CABG).

His clinical research consists of co-authoring 377 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Metastatic Brain Tumor.

Gender
Male

Locations

St. Joseph's Hospital, Hamilton, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
Enrollment Status: Completed
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug, Other
Study Phase: Phase 1/Phase 2
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis
Enrollment Status: Completed
Publish Date: October 18, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

376 Total Publications

Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Journal: The Journal of biological chemistry
Published: August 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Crowther's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile